Co-Founder Katherine Rhodes speaks on panel discussing the gender dimensions of AI/ML in the Life Sciences

CellCipher CEO and Co-Founder Katherine Rhodes was invited to speak at a panel hosted by Women in Bio and Sterling Bay on January 31st, 2024. Discussion focused on gender biases in current implementations of artificial intelligence and machine learning in biotech and how use these technologies can better serve women and minorities.

Next
Next

CellCipher wins $150k investment from George Schultz Innovation Fund